Results 81 to 90 of about 3,238 (182)

Progression and Metastasis of Lung Cancer: Clinical Features, Molecular Mechanisms, and Clinical Managements

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Lung cancer represents a significant global health threat. Despite progress in treatment, metastasis continues to present a major clinical challenge. This article reviews the metastases of lung cancer to the liver, bone, and brain, focusing on clinical symptoms, molecular mechanisms, and treatment strategies.
Yunkui Zhang   +4 more
wiley   +1 more source

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer

open access: yesResearch and Reports in Urology, 2021
Kazuhiro Watanabe,1,* Gen Kawaguchi,2,* Yohei Ikeda,3 Noboru Hara,1 Tsutomu Nishiyama1 1Department of Urology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Niigata, Japan; 2Department of ...
Watanabe K   +4 more
doaj  

Oligometastases in prostate cancer: Ablative treatment

open access: yesWorld Journal of Clinical Oncology, 2019
Technological advances in radiotherapy have led to the introduction of techniques such as stereotactic body radiation therapy (SBRT), allowing the administration of ablative doses. The hypothesis that oligometastatic disease may be cured through local eradication therapies has led to the increasing use of SBRT in patients with this type of disease.
Palacios-Eito, Amalia   +3 more
openaire   +2 more sources

Chemoradioimmunotherapy versus chemoimmunotherapy or chemoradiotherapy in extensive‐stage small‐cell lung cancer: A retrospective analysis of survival outcomes

open access: yesPrecision Radiation Oncology, Volume 9, Issue 4, Page 295-303, December 2025.
This study assessed the impact of IO and the role of TRT in ES‐SCLC treatment.The CRT‐IO group had longer mOS than the CT‐IO and CRT group.TRT may be beneficial in the IO era, CRT may be also a viable option considering economic and physical factors.
Jinmin Han   +4 more
wiley   +1 more source

Oligometastases [PDF]

open access: yesJournal of Thoracic Oncology, 2018
Joachim Widder, Joyce Lodeweges
openaire   +2 more sources

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases

open access: yesFrontiers in Oncology, 2019
During the natural history of oncologic diseases, approximately 20–40% of patients affected by cancer will develop brain metastases. Non-small lung cancer, breast cancer, and melanoma are the primaries that are most likely to metastasize into the brain ...
Rosario Mazzola   +6 more
doaj   +1 more source

Hypofractionated Stereotactic Radiation Therapy for Metastatic Adenocarcinoma ex Goblet Cell Carcinoid of the Appendix: Case Report and Literature Review

open access: yesCase Reports in Oncology, 2019
Adenocarcinoma ex-goblet carcinoid (ADA ex-GCC) is a rare and aggressive subtype of goblet cell carcinoid, a distinct tumor of the appendix characterized by both neuroendocrine and glandular differentiation.
Joseph W. Clyde, Alan W. Katz
doaj   +1 more source

Synchronous or Metachronous Oligometastases [PDF]

open access: yesJournal of Thoracic Oncology, 2017
Joachim Widder, Joyce Lodeweges
openaire   +2 more sources

Oligometastases for Clinicians: Size Matters [PDF]

open access: yesJournal of Clinical Oncology, 2021
Philippe Girard   +5 more
openaire   +2 more sources

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years

open access: yesFrontiers in Oncology, 2019
Purpose and Objective(s): We sought to analyze the long-term follow-up of patients treated with hypofractionated, stereotactic radiotherapy (HSRT) for oligometastases from malignancies other than breast or prostate cancer.Materials and Methods: From 2001
Khush S. Aujla   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy